University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Hodgkin Disease

Interventions: Drug: Lenalidomide (Revlimid®)

First Posted Date: 2007-05-25

Last Posted Date: 2020-09-18

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT00478959

CVD Risk Reduction Trial

Not Applicable

Completed

Conditions: Cardiovascular Disease

First Posted Date: 2007-05-15

Last Posted Date: 2007-05-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 827

Registration Number: NCT00473785

Locations: 🇨🇦
Grey-Bruce Health Unit, Owen Sound, Ontario, Canada
🇨🇦
Laurentian University / Sudbury and District Health Unit, Sudbury, Ontario, Canada
🇨🇦
University Health Network / Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada

Study of Methotrexate in Lupus Erythematosus

Phase 3

Completed

Conditions: Systemic Lupus Erythematosus

First Posted Date: 2007-05-07

Last Posted Date: 2007-05-07

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 86

Registration Number: NCT00470522

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)

Phase 2

Completed

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Erlotinib

First Posted Date: 2007-04-19

Last Posted Date: 2018-02-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 25

Registration Number: NCT00462995

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada
🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib

Phase 4

Terminated

Conditions: Chronic Myeloid Leukemia
Chromosome Abnormality
Gastrointestinal Stromal Cell Tumors

First Posted Date: 2007-04-18

Last Posted Date: 2009-02-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 68

Registration Number: NCT00461929

Locations: 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

First Posted Date: 2007-03-19

Last Posted Date: 2012-06-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 12

Registration Number: NCT00448695

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Safety of Tranexamic Acid in Reducing Bleeding in Adults Undergoing Spinal Surgery

Phase 3

Completed

Conditions: Spine Surgery

Interventions: Drug: Tranexamic acid
Drug: Placebo

First Posted Date: 2007-03-07

Last Posted Date: 2007-11-30

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 151

Registration Number: NCT00444470

Locations: 🇨🇦
Trillium Health Centre, Mississauga, Ontario, Canada
🇨🇦
Department of Anesthesia and Orthopedics; Toronto Western Hospital, Toronto, Ontario, Canada
🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada

Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients

Completed

Conditions: Transplant

First Posted Date: 2007-02-19

Last Posted Date: 2008-04-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 150

Registration Number: NCT00436384

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression

Completed

Conditions: Ocular Hypertension
Glaucoma

First Posted Date: 2007-01-22

Last Posted Date: 2014-05-21

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 74

Registration Number: NCT00424996

Locations: 🇨🇦
University of Toronto; Toronto Western Hospital, Toronto, Ontario, Canada

The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause

Phase 3

Completed

Conditions: Osteoporosis
Bone Density
Osteopenia
Post-Menopause

Interventions: Device: Juvent 1000 Dynamic Motion Therapy (DMT) Platform

First Posted Date: 2007-01-11

Last Posted Date: 2010-04-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 202

Registration Number: NCT00420940

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy